Multicenter randomized phase II study prevention of chemotherapy induced stomatitis with the steroid component mouthwash in woman with breast cancer

Multicenter randomized phase II study prevention of chemotherapy induced stomatitis with the steroid component mouthwash in woman with breast cancer - Multicenter randomized phase II study prevention of chemotherapy induced stomatitis with the steroid component mouthwash in woman with breast cancer

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs071180022

Enrollment

120

Registered

2019-02-22

Start date

2018-01-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer Breast cancer, chemotherapy induced stomatitis

Interventions

Control group: Patients will recieve chemotherapy every 3 week. Interventional group: Beginning on day 1 of cycle1, patients will recieve chemotherapy with 10ml of dexamethazone 0.5 mg per 5 mL oral

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients who is going to have chemotherapy, patients without stomatitis

Exclusion criteria

Exclusion criteria: Patients who have metastatic disease

Design outcomes

Primary

Measure	Time frame
Incidence of all grade stomatitis	—

Secondary

Measure	Time frame
Incidence of stomatitis according grade, Incidence of dysgeusia, nutrition status, completion rates of chemotherapy, relative dose intensity	—

Contacts

Public ContactSayaka Kuba

Nagasaki University

skuba@nagasaki-u.ac.jp+81-95-819-7316

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026